Vir Biotechnology, Inc. (in Europe, Humabs BioMed, is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial...See more
Headquarter United States of America |
Countries of operation United States of America, Australia, Singapore |
Year founded 2016 (8 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Biotechnician
Executive